ClinicalTrials.gg
CompletedNCT06435052Updated Sep 29, 2026

Efficacy of EMDR Versus CBT for Post-Traumatic Stress Disorder in Pakistan

An interventional study of Eye Movement Desensitization and Reprocessing (EMDR) Therapy and Cognitive Behavioral Therapy (CBT) in Post-Traumatic Stress Disorder, Depression and Anxiety, sponsored by Khushal Khan Khattak Univeristy, Karak, Pakistan. Completed at 3 sites in Pakistan. Open to participants aged 15 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Khushal Khan Khattak Univeristy, Karak, Pakistan · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled May 2022, registered Feb 2023).
Updated Sep 29, 2026Now CompletedStart date moved+9 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
15 Years to 60 Years
Sex
All
01

Study summary

This randomized controlled trial compares Eye Movement Desensitization and Reprocessing (EMDR) therapy with Cognitive Behavioral Therapy (CBT) for the treatment of post-traumatic stress disorder (PTSD) in Pakistan. The study examines whether EMDR is at least as effective as CBT in reducing PTSD symptoms over time. It also assesses changes in symptoms of depression and anxiety that commonly occur alongside PTSD. Participants are randomly assigned to receive either EMDR or CBT, and their symptoms are assessed at different stages of treatment and follow-up.

Read the detailed description

This study is a multi-center, single-blind, two-group randomized controlled trial designed to compare Eye Movement Desensitization and Reprocessing (EMDR) therapy with Cognitive Behavioral Therapy (CBT) for the treatment of post-traumatic stress disorder (PTSD) and associated symptoms of depression and anxiety.

The study is conducted in sequential phases. During the initial phase, the psychometric properties of the assessment measures are examined and treatment fidelity is evaluated to determine whether EMDR and CBT are delivered consistently and in accordance with their respective treatment protocols. The subsequent phase focuses on the comparative clinical effectiveness of EMDR and CBT.

Eligible participants with PTSD are randomly allocated to either the EMDR or CBT treatment condition using a covariate-adaptive stratified randomization procedure with a 1:1 allocation ratio. Treatment is delivered face-to-face by clinical psychologists trained in the respective psychotherapeutic approaches. The number of treatment sessions varies according to participants' clinical needs and symptom severity.

The primary objective is to examine whether EMDR is non-inferior to CBT in reducing PTSD symptoms. Additional objectives are to examine changes in PTSD symptoms over the course of treatment and follow-up, assess changes in associated depressive and anxiety symptoms, and explore the relationship between changes in PTSD symptoms and changes in these comorbid symptoms.

PTSD symptoms are assessed using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). Depressive symptoms are assessed using the Hamilton Depression Rating Scale (HDRS), and anxiety symptoms are assessed using the State-Trait Anxiety Inventory (STAI). Assessments are conducted at baseline, during treatment, at the end of treatment, and at follow-up.

Treatment fidelity is also evaluated by assessing therapists' adherence to the EMDR and CBT protocols and their competence in delivering the interventions.

02

Conditions studied

  • Post-Traumatic Stress Disorder
  • Depression
  • Anxiety

Keywords

  • Post-Traumatic Stress Disorder
  • Eye Movement Desensitization and Reprocessing
  • Trauma-Focused Cognitive Behavioral Therapy
  • Depressive Symptoms
  • Anxiety Symptoms
  • Comorbidity
  • Randomized Controlled Trial
  • Pakistan
03

In context

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

This study's enrollment of 80 is above the median of 69 across 2,203 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Khushal Khan Khattak Univeristy, Karak, Pakistan is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Sep 29, 2026. See what changed

Ages eligible
15 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 15 to 60 years.
  • Confirmed diagnosis of post-traumatic stress disorder (PTSD), with PTSD identified as the primary clinical condition.
  • Associated symptoms of depression and anxiety at screening.
  • Able to participate in face-to-face psychotherapy and perform the basic eye and hand movements required for the treatment procedures.
  • Able to provide and communicate sufficiently to participate meaningfully in assessment and psychotherapy.

Exclusion criteria

Exclusion Criteria:

  • Younger than 15 years or older than 60 years.
  • Significant limitations in eye or hand movement, or inability to perform the basic movements required for participation in the treatment procedures.
  • Prolonged unconsciousness or otherwise unable to maintain sufficient consciousness to participate meaningfully in assessment or psychotherapy.
  • Does not meet the screening criteria for PTSD, or PTSD is not the primary clinical condition.
  • Severe intellectual impairment that substantially limits the ability to understand, communicate, or participate in the assessment and psychotherapy procedures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Eye Movement Desensitization and Reprocessing (EMDR) Therapy

    Participants assigned to this arm received face-to-face Eye Movement Desensitization and Reprocessing (EMDR) therapy delivered by clinical psychologists trained in EMDR. Treatment followed an eight-stage EMDR protocol for PTSD, with culturally adapted procedures used where appropriate. The number of sessions varied according to symptom severity and clinical need, generally ranging from 6 to 14 sessions, typically delivered once per week. PTSD, depressive, and anxiety symptoms were assessed at baseline, during treatment, at the end of treatment, and at follow-up

    Behavioral: Eye Movement Desensitization and Reprocessing (EMDR) Therapy

  • Active comparator
    Cognitive Behavioral Therapy (CBT)

    Participants assigned to this arm received face-to-face Cognitive Behavioral Therapy (CBT) delivered by clinical psychologists trained in CBT. Treatment followed a structured trauma-focused CBT protocol, with culturally adapted procedures used where appropriate. The number of sessions varied according to symptom severity and clinical need, generally ranging from 6 to 14 sessions, typically delivered once per week. PTSD, depressive, and anxiety symptoms were assessed at baseline, during treatment, at the end of treatment, and at follow-up.

    Behavioral: Cognitive Behavioral Therapy (CBT)

Interventions

  • BehavioralEye Movement Desensitization and Reprocessing (EMDR) Therapy

    Eye Movement Desensitization and Reprocessing (EMDR) therapy was delivered face-to-face by clinical psychologists trained and certified in EMDR. Treatment followed an eight-stage EMDR protocol for post-traumatic stress disorder (PTSD), incorporating culturally adapted procedures where appropriate for the Pakistani clinical context. Treatment included history-taking and treatment planning, preparation, assessment, desensitization using bilateral stimulation, installation of adaptive cognitions, body scan, closure, and reevaluation. The number of sessions was determined according to participants' symptom severity and clinical needs and generally ranged from 6 to 14 sessions, typically delivered once per week.

  • BehavioralCognitive Behavioral Therapy (CBT)

    Cognitive Behavioral Therapy (CBT) was delivered face-to-face by clinical psychologists trained and certified in CBT. Treatment followed a structured trauma-focused CBT protocol for post-traumatic stress disorder (PTSD), with culturally adapted procedures used where appropriate for the Pakistani clinical context. Treatment included assessment and engagement, psychoeducation, relaxation, affective modulation, cognitive coping and restructuring, trauma narrative work, exposure-based procedures, caregiver involvement where appropriate, and enhancement of safety. The number of sessions was determined according to participants' symptom severity and clinical needs and generally ranged from 6 to 14 sessions, typically delivered once per week.

06

What researchers measure

Primary outcomes

  1. Post-traumatic stress disorder symptoms

    PTSD symptom severity was assessed using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). CAPS-5 scores were collected at baseline, during treatment, at the end of treatment, and at follow-up to evaluate changes in PTSD symptoms over time and to compare the EMDR and CBT treatment groups.

    Time frame: Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)

Secondary outcomes

  1. Depressive symptoms

    Depressive symptoms were assessed using the Hamilton Depression Rating Scale (HDRS). Scores were collected at baseline, during treatment, at the end of treatment, and at follow-up to evaluate changes in depressive symptoms over time in the EMDR and CBT treatment groups.

    Time frame: Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)

  2. Anxiety symptoms

    Anxiety symptoms were assessed using the State-Trait Anxiety Inventory (STAI). Scores were collected at baseline, during treatment, at the end of treatment, and at follow-up to evaluate changes in anxiety symptoms over time in the EMDR and CBT treatment groups.

    Time frame: Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)

07

Study locations

3 sites
  • Dr Farzana Bashir Clinic, Gulberg Green Office# G-67, Opal Sqaure, Islamabad (Wellness Clinic )
    Islamabad, 4400, Pakistan
  • Paraplegic Center Peshawar
    Peshawar, 25000, Pakistan
  • Psychiatry Unit & Rehabilitation Center, Lady Reading Hospital
    Peshawar, 25000, Pakistan
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared. The study involves sensitive mental health, trauma-related, and clinical information, and the consent and ethical framework for the study did not provide for public or external sharing of individual-level participant data. Aggregate study findings may be reported in publications and other research outputs.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2022 to primary completion in Feb 2024, 21 months.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 21 months is below that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 29, 2026: start Aug 2022 → May 2022, primary completion Aug 2024 → Feb 2024 and completion Aug 2025 → Mar 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 1, 2023
First posted
May 30, 2024
StartActual
May 10, 2022was Aug 2022
Primary completionActual
Feb 28, 2024was Aug 2024
CompletionActual
Mar 1, 2024was Aug 2025
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Sep 29, 2026
Sites
3 sites added, 1 site removed
Show 3 added (3 Pakistan)
  • Dr Farzana Bashir Clinic, Gulberg Green Office# G-67, Opal Sqaure, Islamabad (Wellness Clinic ) · Islamabad, Pakistan
  • Paraplegic Center Peshawar · Peshawar, Pakistan
  • Psychiatry Unit & Rehabilitation Center, Lady Reading Hospital · Peshawar, Pakistan
Show 1 removed
  • Anwar Khan · Karak, Pakistan
Sep 29, 2026
Start date
Aug 15, 2022→May 10, 2022
Sep 29, 2026
Primary completion
Aug 15, 2024→Feb 28, 2024 (actual)
Sep 29, 2026
Study completion
Aug 15, 2025→Mar 1, 2024 (actual)
Sep 29, 2026
Enrollment
200 (estimated)→80 (actual)
Sep 29, 2026
Eligibility
Minimum age 18 Years→15 Years; Criteria largely rewritten (16 changes)
What changed in the criteria
Inclusion criteria
  • Removedreverse of the exclusion critera
  • AddedAged 15 to 60 years.
  • AddedConfirmed diagnosis of post-traumatic stress disorder (PTSD), with PTSD identified as the primary clinical condition.
  • AddedAssociated symptoms of depression and anxiety at screening.
  • AddedAble to participate in face-to-face psychotherapy and perform the basic eye and hand movements required for the treatment procedures.
  • AddedAble to provide informed consent and communicate sufficiently to participate meaningfully in assessment and psychotherapy.
Exclusion criteria
  • RemovedThe following patients will be excluded:
  • RemovedPatients below the age of 15 years and above 60 years, since this study is neither on children nor on old aged patients;
  • RemovedPatients who can't move their hands and eyes/or can't perform basic movements;
  • RemovedPatients who are unconscious for longer periods and unable to recover consciousness;
  • AddedYounger than 15 years or older than 60 years.
  • AddedSignificant limitations in eye or hand movement, or inability to perform the basic movements required for participation in the treatment procedures.
  • AddedProlonged unconsciousness or otherwise unable to maintain sufficient consciousness to participate meaningfully in assessment or psychotherapy.
  • EditedPatientsDoes not meetingmeet the basic screening criteria offor PTSD/, or PTSD is not the main problem;primary clinical condition.
  • RemovedPatients with severe intellectual impairments, since such patients are difficult to communicate
  • AddedSevere intellectual impairment that substantially limits the ability to understand, communicate, or participate in the assessment and psychotherapy procedures.
Sep 29, 2026
Interventions
Added Behavioral: Eye Movement Desensitization and Reprocessing (EMDR) Therapy·Behavioral: Cognitive Behavioral Therapy (CBT); removed Behavioral: Eye Movement Desensitization & Reprocessing Therapy·Behavioral: Cognitive Behavioral Therapy. Arm changed Eye Movement Desensitization & Reprocessing Therapy→Eye Movement Desensitization and Reprocessing (EMDR) Therapy; Cognitive Behavioral Therapy→Cognitive Behavioral Therapy (CBT)
Sep 29, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedPost-traumatic stress disorder symptomsTime frame: 2 years → Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)
Sep 29, 2026
Secondary outcomes
1 edited, 1 added
What changed in the outcomes
  • EditedDepressive and Anxiety SymptomssymptomsTime frame: 2 years → Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)
  • AddedAnxiety symptomsTime frame: Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)
Sep 29, 2026
Title
Efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan→Efficacy of EMDR Versus CBT for Post-Traumatic Stress Disorder in Pakistan
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Recruiting→Completed
    3 sites added, 1 site removed
    Show 3 added (3 Pakistan)
    • Dr Farzana Bashir Clinic, Gulberg Green Office# G-67, Opal Sqaure, Islamabad (Wellness Clinic ) · Islamabad, Pakistan
    • Paraplegic Center Peshawar · Peshawar, Pakistan
    • Psychiatry Unit & Rehabilitation Center, Lady Reading Hospital · Peshawar, Pakistan
    Show 1 removed
    • Anwar Khan · Karak, Pakistan
    Start date Aug 15, 2022→May 10, 2022
    Primary completion Aug 15, 2024→Feb 28, 2024 (now actual)
    Study completion Aug 15, 2025→Mar 1, 2024 (now actual)
    Enrollment 200 (estimated)→80 (actual)
    Eligibility Minimum age 18 Years→15 Years; Criteria largely rewritten (16 changes)
    What changed in the criteria
    Inclusion criteria
    • Removedreverse of the exclusion critera
    • AddedAged 15 to 60 years.
    • AddedConfirmed diagnosis of post-traumatic stress disorder (PTSD), with PTSD identified as the primary clinical condition.
    • AddedAssociated symptoms of depression and anxiety at screening.
    • AddedAble to participate in face-to-face psychotherapy and perform the basic eye and hand movements required for the treatment procedures.
    • AddedAble to provide informed consent and communicate sufficiently to participate meaningfully in assessment and psychotherapy.
    Exclusion criteria
    • RemovedThe following patients will be excluded:
    • RemovedPatients below the age of 15 years and above 60 years, since this study is neither on children nor on old aged patients;
    • RemovedPatients who can't move their hands and eyes/or can't perform basic movements;
    • RemovedPatients who are unconscious for longer periods and unable to recover consciousness;
    • AddedYounger than 15 years or older than 60 years.
    • AddedSignificant limitations in eye or hand movement, or inability to perform the basic movements required for participation in the treatment procedures.
    • AddedProlonged unconsciousness or otherwise unable to maintain sufficient consciousness to participate meaningfully in assessment or psychotherapy.
    • EditedPatientsDoes not meetingmeet the basic screening criteria offor PTSD/, or PTSD is not the main problem;primary clinical condition.
    • RemovedPatients with severe intellectual impairments, since such patients are difficult to communicate
    • AddedSevere intellectual impairment that substantially limits the ability to understand, communicate, or participate in the assessment and psychotherapy procedures.
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedPost-traumatic stress disorder symptomsTime frame: 2 years → Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)
    Secondary outcomes 1 edited, 1 added
    What changed in the outcomes
    • EditedDepressive and Anxiety SymptomssymptomsTime frame: 2 years → Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)
    • AddedAnxiety symptomsTime frame: Baseline (before treatment), mid-treatment (approximately halfway through the treatment course), end of treatment (following completion of treatment), and follow-up (approximately 1 to 3 months after treatment completion)
    Interventions Added Behavioral: Eye Movement Desensitization and Reprocessing (EMDR) Therapy·Behavioral: Cognitive Behavioral Therapy (CBT); removed Behavioral: Eye Movement Desensitization & Reprocessing Therapy·Behavioral: Cognitive Behavioral Therapy. Arm changed Eye Movement Desensitization & Reprocessing Therapy→Eye Movement Desensitization and Reprocessing (EMDR) Therapy; Cognitive Behavioral Therapy→Cognitive Behavioral Therapy (CBT)
    Title Efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan→Efficacy of EMDR Versus CBT for Post-Traumatic Stress Disorder in Pakistan
    + 6 other changes: verification date, description, conditions, design details, data sharing statement and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06435052
Lead sponsor
Khushal Khan Khattak Univeristy, Karak, Pakistan
Responsible party
Dr. Anwar Khan (Dr. Anwar Khan, Assistant Professor of Organizational Psychology, Khushal Khan Khattak Univeristy, Karak, Pakistan) — Principal investigator
First posted
May 30, 2024
Start date
May 10, 2022
Primary completion
Feb 28, 2024
Completion
Mar 1, 2024
Last update
Sep 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion